A combination of enzalutamide and androgen deprivation therapy (ADT) significantly
Read moreHome » Medications »
Semi-automated contracting system to accelerate partnering in AI-powered drug discovery
One of the main impediments in partnerships between the AI
Read moreNew implant, vaccine trial offer fresh HIV hope
Microscopic image of an HIV-infected T cell. Credit: NIAID A
Read moreThe safer way to ease post-surgical pain
(HealthDay)—For people recovering from surgery or dealing with a painful
Read moreOne step closer to chronic pain relief
Sortilin, which is a protein expressed on the surface of
Read moreResearchers influence CDC’s clarification on prescribing opioids for cancer pain
To reduce the number of people who may misuse, abuse,
Read moreOnline Rx startups offer convenience but also raise concerns
How do you get men excited about decades-old pills for
Read moreLaw backs doctors who prescribe opioids to the dying
Some doctors fear litigation and professional ruin if they are
Read moreDupilumab cuts exacerbations in late-onset asthma
(HealthDay)—Dupilumab is associated with significantly reduced severe exacerbation rates in
Read moreAlbireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat for the Treatment of NAFLD/NASH
BOSTON, April 11, 2019 (GLOBE NEWSWIRE) — Albireo Pharma, Inc.
Read more